The authors investigate the widely used T cell transfer colitis model, originally established by Powrie and colleagues. They show that depending on their microbiota composition recipient animals are differentially susceptible to colitis induced by T bet-proficient and -deficient naive T cells. These data emphasize the importance of host-microbiome interactions in colitis induction and development and clarify an outstanding issue with respect to the Powrie model, i.e conflicting data on the requirement of Th1 T cells.
The manuscript is very concisely written and all conclusions are supported by clearly presented data. I recommend publication of this study. • The authors show a different susceptibility to colitis as a result of different microbiome composition. In their previous publication they emphasized the importance of the myeloid lineage to the colitis phenotype, and specifically the interaction between myeloid cells and transferred T cells. Can they comment on if there any effect of the microbiota on the myeloid cell composition or function in these mice, prior or following colitis induction?
Reviewer: 2
Comments to the Author This study shows that the gut microbiome drives colitis-inducing potential of T-bet deficient Th cells in RAg-/-mice. Since there has been conflicting data on the role of Tbet+ T cells in RAG-/-, this study clarifies that the microbial composition of mice are different at various facilities and show through fecal transplantation that its the type of microbes present that drive this phenotype through the Tbet cells. The authors suggest that its the type of microbes present evident based on fecal transplant however, it can not be rules out that its metabolites or other functional microbial derived products. It would be useful to measure short chain fatty acids. As well, they suggest the mechanism is through Th17 cells yet segmented filamentous bacteria drive Th17 expansion in the gut but these microbes didn't appear in the microbiome analysis. Although the authors do state that mice were SFB negative and then tested positive post-transplant. I find this confusing so it needs better explanation. This manuscript would be strengthen by: 1) use Lefse plots to show differences in bacterial taxa 2) at least use predictive software like PICRUST to look at bacterial function 3) measure short chain fatty acids in the microbiomes 4) the sample size for the microbiome analysis is 3-5 which is unacceptable. The sample size must be >5 and cage effects must be accounted for in the design (is they why you co-housed?) 5) clarify the role of SFB
First Revision -authors' response 28-Jul-2017
Dear Prof Annunziato, thank you for the critical assessment of our manuscript "The intestinal microbiota determines the colitis-inducing potential of T-bet-deficient Th cells".
We are delighted that both reviewers share our enthusiasm about the study.
We have carefully taken the reviewer's advice into account and edited the manuscript accordingly. Please find below our point-by-point response to the reviewer's comments.
Reviewer 1

Comments to the Author
The authors investigate the widely used T cell transfer colitis model, originally established by Powrie and colleagues. They show that depending on their microbiota composition recipient animals are differentially susceptible to colitis induced by T bet-proficient and -deficient naive T cells. These data emphasize the importance of host-microbiome interactions in colitis induction and development and clarify an outstanding issue with respect to the Powrie model, i.e conflicting data on the requirement of Th1 T cells. The manuscript is very concisely written and all conclusions are supported by clearly presented data. I recommend publication of this study. minor comments and suggestions for edits and additions
Comment 1 Figure 1E-G shows that Tbet-deficient T cells express higher levels of rorgt and il17 upon transfer, as also shown in the previous publication by Zimmermann J et al (ref 3). a. Are the Rorgt+ cells only IL17A+ or are they IFNy+ as well? Are some of them double positive for IFNg and IL17A? -This is easy to solve by gating -gate on the Rorgt+ cells and check their cytokine staining
Author's response For technical reasons, we have measured ROR-t and cytokine expression of the T cells in separate flow cytometry panels and are thus unfortunately unable to gate on ROR-t+ cells to directly comment on their cytokine profile. However, the question of the reviewer can be answered indirectly from the cytokine data presented in Figure 1 H: In both T-bet-dependent and T-bet-independent recipients, T-bet-deficient Th cells expressed IL-17A at increased frequencies compared with WT. However, whereas in T-bet-independent recipients half of these IL-17A+ T cells coexpressed IFN-, only 25% of IL-17A+ T cells coexpressed IFN- in T-bet-dependent recipients. Author's response
We have included the information about the composition of the myeloid compartment in the revised version of the manuscript as Supporting Information Fig. 3 . In 'T-bet-dependent' Rag1 -/-recipients, monocytes, macrophages, and neutrophils were strongly reduced in colitis induced by T-bet-deficient compared with WT Th cells. This contrasts our findings with T-bet-independent Rag1 -/-recipients, where Th cells in T-bet-dependent recipients is a secondary effect of reduced numbers of T cells rather than directly mediated by the microbiota.
Reviewer 2
Comments to the Author
This study shows that the gut microbiome drives colitis-inducing potential of T-bet deficient Th cells in Rag-/-mice. Since there has been conflicting data on the role of Tbet+ T cells in Rag-/-, this study clarifies that the microbial composition of mice are different at various facilities and show through fecal transplantation that its the type of microbes present that drive this phenotype through the Tbet cells. Comment 1 The authors suggest that its the type of microbes present evident based on fecal transplant however, it cannot be ruled out that it is metabolites or other functional microbial derived products.
Author's response
We agree with the reviewer that the differential abundance of microbiota-derived metabolites could shape the susceptibility to colitis induced by T-bet-deficient Th cells. However, differential metabolite abundance would be a secondary consequence of the altered composition and thus the primary causal reason for differential colitis susceptibility would still be microbiota composition. We have clarified that the exact mechanism of how the microbiota influences colitis susceptibility remains to be determined on page 6 lines 5-8: "Overall, it remains to be determined which bacterial taxa differentially activate T-bet-sufficient or T-bet-deficient Th cells to induce colitis and how they do it, e.g. by microbiota-derived metabolites or direct interaction with the host."
Comment 2 It would be useful to measure short chain fatty acids. As well, they suggest the mechanism is through Th17 cells yet segmented filamentous bacteria drive Th17 expansion in the gut but these microbes didn't appear in the microbiome analysis. Although the authors do state that mice were SFB negative and then tested positive post-transplant. I find this confusing so it needs better explanation. This manuscript would be strengthen by: 1) use Lefse plots to show differences in bacterial taxa
Author's response
We thank the reviewer for this helpful suggestion and have incorporated LefSE plots in Fig. 2 and Supporting Information Fig. 7 of the revised version of the manuscript.
2) at least use predictive software like PICRUST to look at bacterial function
We have used PICRUSt to predict the differential abundance of pathways in the two metagenomes, susceptible and resistant to colitis induced by T-bet-deficient Th cells. 'T-bet-independent' mice revealed many pathways that were absent from 'T-bet-dependent' microbiomes thus reflecting the increased number of different bacterial families in these mice. We have added the PICRUSt analysis in Fig. 2E . However, we would like to stress, that it remains highly speculative whether and which differentially abundant pathways are causative for the difference in colitis susceptibility.
3) measure short chain fatty acids in the microbiomes
Author's response Short chain fatty acids produced mainly by Clostridia (Atarashi et al., Science, 2011) were shown to regulate the numbers of colonic Tregs and suppress colitis (Smith et al., Science, 2013) . However, as we now demonstrate in Supporting Information Fig. 2 , the number of colonic regulatory T cells was similar in 'T-bet-dependent' and 'T-bet-independent' Rag1 -/-recipients. Moreover, Smith and colleagues found that SCFA reduced colitis severity when regulatory T cells were cotransferred along with the naïve colitogenic T cells. However, when only naïve T cells were transferred -as we have done in our manuscript -there was no effect of SCFA on colitis severity (Smith et al., Science, 2013 Figure S20B ). In conclusion, we think that the measurement of SCFA in the intestinal content or feces would not substantiate the conclusions of the manuscript.
Comment 3
The sample size for the microbiome analysis is 3-5 which is unacceptable. The sample size must be >5 and cage effects must be accounted for in the design (is they why you co-housed?)
Despite the relatively small sample size, our microbiome analyses between 'T-bet-dependent' and 'T-bet-independent' microbiomes, revealed statistically significant differences. We can thus conclude that the analysis is sufficiently powered to identify the signature taxa that distinguish the two microbiomes. Cage effects are accounted for in both the colitis severity experiments and the microbiome analyses: In the former, Rag1 -/-mice receiving either WT or T-bet-deficient Th cells were always cohoused in the same cage. Obviously, however, 'T-bet-dependent' and 'T-bet-independent' Rag1 -/-recipients were housed in different cages to prevent exchange of their microbiota. For the microbiome analysis, feces from two different cages ('T-bet-independent') and three different cages ('T-bet-dependent') were used.
Comment 4
Clarify the role of SFB Author's response
We have included the information about the colonization status of the mice with SFB as determined by conventional PCR from fecal DNA on page 5, lines 15-22. SFB are absent from the remainder of the microbiome analysis as our 16S sequencing pipeline is unable to resolve SFB on the genus level. We do not think that colitis induction by T-bet-deficient Th cells selectively in 'T-bet-independent' Rag1 -/-mice is due to Th17 cells: Our own previous results demonstrated that IL-17 is not pathogenic but rather protective in colitis induced by WT or T-bet-deficient Th cells (Zimmermann et al., Muc Immunol, 2016) .
In the present manuscript, we speculate that multifunctional IFN-+IL-17+ double-positive T cellspreviously implicated in colitis pathogenesis (Harbour et al., PNAS, 2015 and Ahern et al., Immunity, 2014 ) -could play a role. should therefore check that all the information (including author names) is correct as changes will NOT be permitted until the proofs stage.
Second Editorial
We look forward to hearing from you and thank you for submitting your manuscript to the European Journal of Immunology. 
